International research team partners with IBM to identify childhood cancer treatments

Smash Childhood Cancer, a research initiative between IBM and a team of international medical researchers, aims to identify new chemical drug candidates to treat childhood brain, kidney, liver and bone cancers.

Advertisement

The research project — led by Dr. Akira Nakagawara, a pediatric oncologist, molecular biologist and CEO at Saga Medical Center Koseikan in Japan — brings together scientists from these five institutions:

  • Connecticut Children’s Medical Center in Hartford
  • University of Connecticut School of Medicine in Farmington
  • The Jackson Laboratory in Bar Harbor, Maine
  • The University of Hong Kong
  • Chiba University in Japan
  • Kyoto University in Japan

IBM is providing the Smash Childhood Cancer researchers free access to World Community Grid, an IBM-funded and managed program that enables scientists to conduct virtual experiments in an effort to identify promising drug candidates for more detailed study.

In recent years, researchers have used the World Community Grid to help determine treatments for Ebola, HIV/AIDS and Zika.

More articles on health IT:
10 things to know about athenahealth
The top 5 ways cybercriminals execute healthcare breaches
Healthcare industry encompasses 34.4% of all breaches

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.